Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Top 10 Trends In Food, Supplement Labeling Litigation

This article was originally published in The Tan Sheet

Executive Summary

Lawyers who took down big tobacco have food and supplement advertising in their crosshairs, industry lawyer Prochnow says. He warns that among the top 10 enforcement trends are cases for unsubstantiated claims, “all natural” claims, dangerous failure to warn, nutrient content claims and “healthy” claims.

You may also be interested in...



Trade Groups Tutor Firms On Protein-Content Calculations

AHPA and CRN worked together on guidance for doing the nutrient math correctly for protein-content labeling on supplement products. The groups recommend that calculations of protein content in nutrient labeling include only proteins that consist of a chain of amino acids connected by peptide bonds.

Trade Groups Tutor Firms On Protein-Content Calculations

AHPA and CRN worked together on guidance for doing the nutrient math correctly for protein-content labeling on supplement products. The groups recommend that calculations of protein content in nutrient labeling include only proteins that consist of a chain of amino acids connected by peptide bonds.

POM Decision Will Free FTC Resources For Other Enforcement

With the POM Wonderful litigation off its desk, FTC will have more resources to bring cases against other advertisers, attorney Mark Ullman warns. Likely target areas in 2013 and beyond include social media marketing and more subtle disease claims.

Related Content

Topics

Related Companies

Latest Headlines
See All
UsernamePublicRestriction

Register

PS106240

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel